MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE
    4.
    发明申请
    MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE 审中-公开
    (3R) - 羟基丁酸(3R) - 羟基丁酸酯的微生物和方法

    公开(公告)号:US20160108442A1

    公开(公告)日:2016-04-21

    申请号:US14893510

    申请日:2014-05-23

    Abstract: Provided herein are non-naturally occurring microbial organisms having a pathway for production of (3R)-hydroxybutyl (3R)-hydroxybutyrate, wherein the organism can further include a (R)-1,3-butanediol pathway, a (3R)-hydroxybutyrate pathway, a (3R)-hydroxybutyryl-CoA pathway, an acetoacetate pathway, an acetoacetyl-CoA pathway, a (3R)-hydroxybutyl-ACP pathway, or an acetoacetyl-ACP pathway. Additionally provided are methods and processes for producing and isolating (3R)-hydroxybutyl (3R)-hydroxybutyrate using the microbial organisms, and various compositions having the (3R)-hydroxybutyl (3R)-hydroxybutyrate. Still further provided are methods of treating or preventing a disease, disorder or condition using the (3R)-hydroxybutyl (3R)-hydroxybutyrate produced by the microbial organisms of the invention.

    Abstract translation: 本文提供了具有(3R) - (3R) - 羟基丁酸生产途径的非天然存在的微生物生物,其中生物体还可包含(R)-1,3-丁二醇途径,(3R) - 羟基丁酸酯 途径,(3R) - 羟基丁酰辅酶A途径,乙酰乙酸途径,乙酰乙酰辅酶A途径,(3R) - 羟基丁基ACP途径或乙酰乙酰-ACP途径。 另外提供了使用微生物生物体(3R) - 羟基丁酸(3R) - 羟基丁酸生产和分离(3R) - 羟基丁酸酯的方法和方法,以及具有(3R) - 羟基丁基(3R) - 羟基丁酸酯的各种组合物。 还提供了使用本发明的微生物生物体产生的(3R) - 羟基丁酸(3R) - 羟基丁酸酯来治疗或预防疾病,病症或病症的方法。

    Microorganisms for Producing 1,3-Butanediol and Methods Related Thereto
    6.
    发明申请
    Microorganisms for Producing 1,3-Butanediol and Methods Related Thereto 审中-公开
    用于生产1,3-丁二醇的微生物及其相关方法

    公开(公告)号:US20160076060A1

    公开(公告)日:2016-03-17

    申请号:US14692630

    申请日:2015-04-21

    CPC classification number: C12P7/18 C12N15/52

    Abstract: Provided herein is a non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway and comprising at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. In some embodiments, the pathway includes reducing equivalents from CO or hydrogen. In certain embodiments, a 1,3-BDO pathway proceeds by way of central metabolites pyruvate, succinate or alpha-ketoglutarate. Also provided herein is a method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.

    Abstract translation: 本文提供了具有1,3-丁二醇(1,3-BDO)途径的非天然存在的微生物生物,并且包含至少一种编码1,3-BDO途径酶的外源核酸,其以足够的量表达以产生1 ,3-BDO。 在一些实施方案中,该途径包括从CO或氢中还原当量。 在某些实施方案中,1,3-BDO途径通过中枢代谢物丙酮酸,琥珀酸或α-酮戊二酸进行。 本文还提供了一种生产1,3-BDO的方法,包括在条件和足够的时间内培养这些微生物以产生1,3-BDO。

    MICROORGANISMS AND METHODS FOR THE PRODUCTION OF CAPROLACTONE
    7.
    发明申请
    MICROORGANISMS AND METHODS FOR THE PRODUCTION OF CAPROLACTONE 审中-公开
    用于生产CAPROLACTONE的微生物和方法

    公开(公告)号:US20150353975A1

    公开(公告)日:2015-12-10

    申请号:US14596072

    申请日:2015-01-13

    Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.

    Abstract translation: 本发明提供了非天然存在的含有己内酯途径的微生物,其具有至少一种编码丁二烯途径酶的外源核酸,其表达量足以产生己内酯。 本发明另外提供了使用这种微生物生物体来制备己内酯的方法,该方法是在条件和足够的时间内培养含本文所述的己内酯途径的非天然存在的微生物生物产生己内酯。

Patent Agency Ranking